Replies to post #1079 on SafeCode Drug Technologies Corp. (fka SAFC)

[Soboks]

If we view the company's current (Filing date of 12-18-2012) FORM 10-Q/A located at URL:
http://www.sec.gov/Archives/edgar/data/1508470/000114420412068331/v330412_10-qa.htm

then we find under section #4 the following:
"The Company has concurrently entered into an agreement with a US - ISRAELI marketing consulting Co called, Strategic Marketing Technologies Corp, whereby they will assist Safecode Drug Technologies Corp to conceptualize and manufacture a prototype of its patent pending medical product for a demonstration and the possible market penetration into the US Department of Defense. The project is estimated to be completed over a period of 6-9 months and will cost $53,000 payable in milestones over the related period".

So it seems that while there may be a period of this stock marking time in a very low cost per share, it seems that good things will eventually come to those that wait. (IMO)